163 related articles for article (PubMed ID: 25196812)
1. Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease.
Marsh A; Schiffelers R; Kuypers F; Larkin S; Gildengorin G; van Solinge W; Hoppe C
Br J Haematol; 2015 Jan; 168(1):135-8. PubMed ID: 25196812
[TBL] [Abstract][Full Text] [Related]
2. Sickle-cell hip necrosis and intraosseous pressure.
Mukisi MM; Bashoun K; Burny F
Orthop Traumatol Surg Res; 2009 Apr; 95(2):134-8. PubMed ID: 19285936
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.
Daltro GC; Fortuna V; de Souza ES; Salles MM; Carreira AC; Meyer R; Freire SM; Borojevic R
Stem Cell Res Ther; 2015 May; 6(1):110. PubMed ID: 26021713
[TBL] [Abstract][Full Text] [Related]
4. Preliminary Results of Multiple Epiphyseal Drilling and Autologous Bone Marrow Implantation for Osteonecrosis of the Femoral Head Secondary to Sickle Cell Disease in Children.
Novais EN; Sankar WN; Wells L; Carry PM; Kim YJ
J Pediatr Orthop; 2015 Dec; 35(8):810-5. PubMed ID: 25551782
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for osteonecrosis of the femoral head in five hundred and ten sickle cell disease paediatric patients.
Ouederni M; Rouag H; Ben Fraj I; Rekaya S; Kouki R; Lamouchi T; Zaiter I; Mellouli F; Bejaoui M; Ben Khaled M
Int Orthop; 2023 Dec; 47(12):2941-2952. PubMed ID: 37452863
[TBL] [Abstract][Full Text] [Related]
6. An overview of pathophysiology and treatment options of osteonecrosis of femoral head in sickle cell disease.
Al-Otaibi ML
Saudi Med J; 2022 Nov; 43(11):1192-1199. PubMed ID: 36379523
[TBL] [Abstract][Full Text] [Related]
7. Managing femoral head osteonecrosis in patients with sickle cell disease.
Al-Mousawi FR; Malki AA
Surgeon; 2007 Oct; 5(5):282-9. PubMed ID: 17958228
[TBL] [Abstract][Full Text] [Related]
8. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.
Worrall D; Smith-Whitley K; Wells L
J Pediatr Orthop; 2016 Mar; 36(2):139-44. PubMed ID: 25705804
[TBL] [Abstract][Full Text] [Related]
10. Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study.
Mukisi-Mukaza M; Manicom O; Alexis C; Bashoun K; Donkerwolcke M; Burny F
Orthop Traumatol Surg Res; 2009 Nov; 95(7):498-504. PubMed ID: 19801210
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery.
Lim SJ; Yeo I; Park CW; Lee H; Park YS; Lee JI
PLoS One; 2020; 15(9):e0238368. PubMed ID: 32881966
[TBL] [Abstract][Full Text] [Related]
12. Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study.
Agrawal AC; Mohapatra E; Nanda R; Bodhey NK; Sakale H; Garg AK
Cureus; 2022 Mar; 14(3):e23556. PubMed ID: 35371856
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and surgical management of femoral head osteonecrosis in sickle cell disease].
Wu H; Yang F; Hernigou P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):886-91. PubMed ID: 17882891
[TBL] [Abstract][Full Text] [Related]
14. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis in sickle cell trait.
Taylor PW; Thorpe WP; Trueblood MC
J Rheumatol; 1986 Jun; 13(3):643-6. PubMed ID: 3735287
[TBL] [Abstract][Full Text] [Related]
16. [Femur head necrosis in sickle cell anemia].
Bömelburg T; Ehringhaus C; Ziegler R; von Lengerke HJ; Timm C
Monatsschr Kinderheilkd; 1986 Apr; 134(4):212-5. PubMed ID: 3702893
[TBL] [Abstract][Full Text] [Related]
17. Early acetabular protrusio following hemiresurfacing of the hip for osteonecrosis in sickle cell disease.
Berend KR; Lilly EG
J South Orthop Assoc; 2003; 12(1):32-7. PubMed ID: 12735623
[TBL] [Abstract][Full Text] [Related]
18. Plasma and local expressions of CircRNA CDR1as are linked with disease severity in patients with non-traumatic osteonecrosis of femoral head.
Jiang B; Zhu SH; Zeng JY; Mao Z
J Orthop Surg Res; 2020 Dec; 15(1):592. PubMed ID: 33298118
[TBL] [Abstract][Full Text] [Related]
19. Global urinary metabolic profiling of the osteonecrosis of the femoral head based on UPLC-QTOF/MS.
Yang G; Zhao G; Zhang J; Gao S; Chen T; Ding S; Zhu Y
Metabolomics; 2019 Feb; 15(3):26. PubMed ID: 30830485
[TBL] [Abstract][Full Text] [Related]
20. A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis.
Hauzeur JP; Malaise M; de Maertelaer V
Int Orthop; 2016 Jul; 40(7):1347-51. PubMed ID: 26728612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
